Pharmacists/Test and Treat.
Do you support it?
Want to know if it passes?
We'll email you when SB 414 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on SB 414.
You're tracking SB 414
We'll email you the moment it moves.
SB 414 — Pharmacists/Test and Treat.
Last action — Passed 1st Reading
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill is in committee in the Senate. Introduced March 24, 2025. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the Senate.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
-
In Committee
Current position in the legislative process.
-
7 sponsors
2 primary, 5 co-sponsors signed on.
-
Bipartisan support
Sponsored across 2 parties (6 R · 1 D) — cross-party backing.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Bill Text
What changed in the latest version
14 added · 15 removedPlain-language change summary
In the latest version of Senate Bill 414, there were minor corrections made to the text, including adjustments in spacing and punctuation. These changes clarify the language but do not alter the bill's intent or requirements. This matters because clear wording helps ensure that everyone understands the regulations being set, which can reduce confusion for healthcare providers and patients alike.
FILED SENATE GENERAL ASSEMBLY OF NORTH CAROLINA MarSESSION 24, 2025 S.B.S 1 SENATE BILL 414 Short Title:
414 SESSION 2025 PRINCIPAL CLERK S D SENATE BILL DRS15177-NB-85 Short Title:
Rules and Operations of the Senate March 25, 2025 A BILL TO BE ENTITLED AN ACT TO ALLOW PHARMACISTS TO TEST AND TREAT FOR CERTAIN ILLNESSES WITH CERTAIN MEDICATIONS APPROVED BY THE BOARD OF PHARMACY, TO PROVIDE FOR FAIR AND EQUITABLE REIMBURSEMENT OF HEALTH CARE SERVICES OR PROCEDURES THAT ARE PERFORMED BY A PHARMACIST WITHIN THAT PHARMACIST'S SCOPE OF PRACTICE AND THAT ARE EQUIVALENT TO SERVICES PERFORMED BY OTHER HEALTH CARE PROFESSIONALS, AND TO APPROPRIATE FUNDS TO THE DEPARTMENT OF INSURANCE.
… (b2) "CLIA-waived test" means a laboratory test approved by the Food and Drug Administration and determined bybythe the Centers for Medicare and Medicaid Services to qualifyqualifyfor for a waiver under the federal Clinical Laboratory Improvement Amendments of 1988 and safe for use in non-laboratory settings.
*DRS15177-NB-85**S414-v-1* General Assembly Of North Carolina Session 2025 (2) Treat influenza, COVID-19, pharyngitis caused by group A streptococcus, and other health conditions screened by utilizing a CLIA-waived test, in accordance with statewide protocols.
SECTION2.(a) Article3ofChapter58oftheGeneralStatutesisamendedArticle3ofChapter58oftheGeneralStatutesisamendedbyadding byadding a new section to read:
A health care facilityfacilitylicensed licensed under Chapter 131E or Chapter 122C of the General Statutes and where healthcare services are provided to patients.
(c) The participation of a pharmacypharmacyin in a drug benefit provider network of a health benefit plan shall not satisfy any requirement that insurers offering health benefit plans include pharmacists in medical benefit provider networks." SECTION 2.(b) G.S.
58-3-223, unless contractingcontractinghealth health careproviders ableto meet healthneeds oftheinsuredareoftheinsured reasonablyare availablereasonablyavailable to the insured without unreasonable delay.
Upon notice or request from the insured, the insurer shall determine whether a health care provider able to meet the needs of the insured is available to the insured without unreasonable delay by reference to the insured's location and the specific medical needs of the insured." Page 2 DRS15177-NB-85Senate Bill 414-First Edition General Assembly Of North Carolina Session 2025 SECTION 2.(d) G.S.
DRS15177-NB-85Senate Bill 414-First Edition Page 3
Compared against the N.C. General Statutes as published AI-generated reading aid — verify against the official bill.
The bill expands the definitions and responsibilities of pharmacists to include testing and treating certain illnesses, allows for their reimbursement for such services, and includes provisions for insurance coverage.
-
N.C.G.S. § 90-85.3
"CLIA-waived test" means a laboratory test approved by the Food and Drug Administration and determined by the Centers for Medicare and Medicaid Services to qualify for a waiver under the federal Clinical Laboratory Improvement Amendments of 1988 and safe for use in non-laboratory settings.
Updates the definition of 'CLIA-waived test' to include approval by the Centers for Medicare and Medicaid Services.
-
N.C.G.S. § 90-85.3
"Clinical pharmacist practitioner" means a licensed pharmacist who meets the guidelines and criteria for such title established by the joint subcommittee of the North Carolina Medical Board and the North Carolina Board of Pharmacy and is authorized to enter into drug therapy management agreements with physicians in accordance with the provisions of G.S. 90-18.4.
Clarifies the definition of 'Clinical pharmacist practitioner' to include authority for drug therapy management agreements.
-
N.C.G.S. § 90-85.3A
A pharmacist may order and perform a CLIA-waived test to do any of the following: (1) Assist with clinical decision making related to the use and monitoring of medications. (2) Treat influenza, COVID-19, pharyngitis caused by group A streptococcus, and other health conditions screened by utilizing a CLIA-waived test, in accordance with statewide protocols.
Allows pharmacists to order and perform CLIA-waived tests for specific health conditions.
-
N.C.G.S. § 58-3-241
(a) The following definitions apply in this section: (1) Healthcare provider. – Either of the following: a. An individual who is licensed, certified, or otherwise authorized under Chapter 90 of the General Statutes to provide healthcare services in the ordinary course of business or practice of a profession or in an approved education or training program. b. A health care facility licensed under Chapter 131E or Chapter 122C of the General Statutes and where healthcare services are provided to patients.
Defines 'healthcare provider' for the purposes of the new section regarding services provided by pharmacists.
-
N.C.G.S. § 58-3-241
(2) Healthcare services. – Any of the following health or medical procedures or services rendered by a healthcare provider: a. Testing, diagnosis, or treatment of a health condition, illness, injury, or disease. This includes testing, diagnosis, or treatment rendered by a pharmacist acting within the pharmacist's scope of practice.
Defines 'healthcare services' to explicitly include services provided by pharmacists.
-
N.C.G.S. § 58-3-241
A health benefit plan offered by an insurer in this State shall cover healthcare services provided by a pharmacist if all of the following conditions are met: (1) The service or procedure was performed within the pharmacist's licensed lawful scope of practice. (2) The health benefit plan would have covered the service if the service or procedure had been performed by another healthcare provider.
Requires health benefit plans to cover services provided by pharmacists under certain conditions.
-
N.C.G.S. § 58-3-230
(d) Insurers that delegate credentialing agreements or requirements for pharmacists licensed under Article 4A of Chapter 90 of the General Statutes or the relevant laws of another state to a contracted healthcare facility shall accept the credentialing for all pharmacists employed by, or contracted with, those healthcare facilities.
Mandates that insurers accept the credentialing of pharmacists for services provided at contracted healthcare facilities.
-
N.C.G.S. § 58-3-200(d)
No insurer shall penalize an insured or subject an insured to the out-of-network benefit levels offered under the insured's approved health benefit plan, including an insured receiving an extended or standing referral under G.S. 58-3-223, unless contracting healthcare providers able to meet health needs of the insured are reasonably available to the insured without unreasonable delay.
Protects insured patients from penalties when seeking services outside of provider networks, provided there are no reasonable alternatives.
-
N.C.G.S. § 58-56-26
(e) Notwithstanding any provision of this Article to the contrary, all requirements relating to the coverage of prescription drugs and pharmacy services under this Chapter that apply to health benefit plans are applicable to a third-party administrator in the same way they are applicable to an insurer.
Ensures that third-party administrators are subject to the same coverage requirements for prescription drugs and pharmacy services as insurers.
-
N.C.G.S. § 58-56A-55
All requirements relating to the coverage of prescription drugs and pharmacy services under this Chapter that apply to health benefit plans are applicable to a pharmacy benefits manager in the same way they are applicable to an insurer.
Extends the same coverage requirements for prescription drugs and pharmacy services to pharmacy benefits managers.
Action History
-
Passed 1st Reading
-
Ref To Com On Rules and Operations of the Senate
-
Filed
Sponsors
- Ralph Hise · Cosponsor
- Bobby Hanig · Cosponsor
- Jim Burgin · Cosponsor
- Gale Adcock · Cosponsor
- Timothy D. Moffitt · Cosponsor
- Carl Ford · Primary
- Dana Jones · Primary
Sponsorship breakdown
Export CSV (upgrade) →2 sponsors · 5 co-sponsors · 172 not signed on
Sponsors (2)
- Carl Ford Republican
- Dana Jones Republican
Co-sponsors (5)
- Ralph Hise Republican
- Bobby Hanig Republican
- Jim Burgin Republican
- Gale Adcock Democratic
- Timothy D. Moffitt Republican
Not signed on (172)
172 members have not signed on to this bill.
Show all 172 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- Who sponsors SB 414?
- SB 414 is sponsored by Ralph Hise (Republican), Bobby Hanig (Republican), Jim Burgin (Republican), Gale Adcock (Democratic), Timothy D. Moffitt (Republican), Carl Ford (Republican), and Dana Jones (Republican).
- What is the current status of SB 414?
- This bill is in committee in the Senate. Introduced March 24, 2025. It must pass committee before a floor vote.
- Where can I track SB 414?
- Track SB 414 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 414
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 414
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →